Search - tctmd.com

Displaying 41 - 52 of 52

Sort: Relevancy | Date

Presentation TVT 2017

Transcatheter Edge-to-Edge Repair of Pacemaker-Associated Tricuspid Regurgitation

Presenter: Azeem Latib, Christopher U. Meduri, Neil Fam, MD

June 15, 2017

Presentation TVT 2017

Incidence, Predictors, and Consequences of Permanent Pacemakers after TAVR

Presenter: Tamim Nazif

June 15, 2017

Presentation TVT 2017

Advances in Temporary Transvenous Pacemakers: The BioTrace Tempo Lead

Presenter: Tamim Nazif

June 15, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

Presentation TVT 2016

Clinical Implications of New LBBB and New Pacemakers After TAVR

Presenter: Azeem Latib

June 16, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

Presentation TVT 2015

Thoughtful Commentary: High Risk for Pacemaker With LV Dysfunction and TAVR

Presenter: Antonio Colombo, A. Pieter Kappetein, Tamim Nazif

June 05, 2015

Presentation TVT 2015

Case Presentation: High Risk for Pacemaker With LV Dysfunction and TAVR

Presenter: Antonio Colombo, A. Pieter Kappetein, Hemal Gada

June 05, 2015

Presentation TVT 2014

New LBBB and Permanent Pacemakers Arent Detrimental in this AS Population

Presenter: Nicolo Piazza

June 07, 2014

Presentation TVT 2014

New LBBB and Permanent Pacemakers Have Significant Consequences

Presenter: Tamim Nazif

June 07, 2014

Presentation TVT 2012

Snapshot III. New Permanent Pacemakers After TAVR: Frequency, Predictors, Outcomes, and "When to Treat" Guidelines

Presenter: Jeffrey Popma

June 03, 2012

Advertisement

Transcatheter Edge-to-Edge Repair of Pacemaker-Associated Tricuspid Regurgitation

Incidence, Predictors, and Consequences of Permanent Pacemakers after TAVR

Advances in Temporary Transvenous Pacemakers: The BioTrace Tempo Lead

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

What TAVR Needs Next . . . and What It’s Getting

Clinical Implications of New LBBB and New Pacemakers After TAVR

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Thoughtful Commentary: High Risk for Pacemaker With LV Dysfunction and TAVR

Case Presentation: High Risk for Pacemaker With LV Dysfunction and TAVR

New LBBB and Permanent Pacemakers Arent Detrimental in this AS Population

New LBBB and Permanent Pacemakers Have Significant Consequences

Snapshot III. New Permanent Pacemakers After TAVR: Frequency, Predictors, Outcomes, and "When to Treat" Guidelines

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content